PAPER Heise V, Filippini N, Trachtenberg AJ, Suri S, Ebmeier KP, Mackay CE
SEARCH RESULTS
329960 RESULTS
PAPER Wang L, Esteban G, Ojima M, Bautista-Aguilera OM, Inokuchi T, Moraleda I, Iriepa I, Samadi A, Youdim MB, Romero A, Soriano E, Herrero R, Fernández Fernández AP, Ricardo-Martínez-Murillo, Marco-Contelles J, Unzeta M
Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
Eur J Med Chem. 2014 Jun 10;80:543-61. Epub 2014 Apr 29 PubMed: 24813882PAPER Li X, Zhao X, Xu X, Mao X, Liu Z, Li H, Guo L, Bi K, Jia Y
Schisantherin A recovers Aβ-induced neurodegeneration with cognitive decline in mice.
Physiol Behav. 2014 Jun 10;132:10-6. Epub 2014 May 8 PubMed: 24813830PAPER Schönhofen P, de Medeiros LM, Chatain CP, Bristot IJ, Klamt F
Cofilin/actin rod formation by dysregulation of cofilin-1 activity as a central initial step in neurodegeneration.
Mini Rev Med Chem. 2014 May;14(5):393-400. PubMed: 24813767PAPER Meli G, Krako N, Manca A, Lecci A, Cattaneo A
Intrabodies for protein interference in Alzheimers disease.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):89-105. PubMed: 24813318PAPER Mancuso C, Santangelo R, Calabrese V
The heme oxygenase/biliverdin reductase system: a potential drug target in Alzheimers disease.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):75-87. PubMed: 24813317PAPER D' Addario C, Di Francesco A, Trabace L, Finazzi Agro' A, Cuomo V, Maccarrone M
Endocannabinoid signaling in Alzheimers disease: current knowledge and future directions.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):61-73. PubMed: 24813316PAPER Nistico' R, Piccinin S, Schepisi C, Ferraina C, Laurenza M, Mango D, Graziani M, Nicoletti F, Mercuri NB, Feligioni M
Pharmacological modulation of long-term potentiation in animal models of Alzheimer's disease.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):37-47. PubMed: 24813314PAPER Fiorenza MT, Dardis A, Canterini S, Erickson RP
Cholesterol metabolism-associated molecules in late onset Alzheimer's disease.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):23-35. PubMed: 24813313PAPER Cervia D, Perrotta C, Moscheni C, De Palma C, Clementi E
Nitric oxide and sphingolipids control apoptosis and autophagy with a significant impact on Alzheimer's disease.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):11-22. PubMed: 24813312PAPER Yang C, Liu Y, Ni X, Li N, Zhang B, Fang X
Enhancement of the nonamyloidogenic pathway by exogenous NGF in an Alzheimer transgenic mouse model.
Neuropeptides. 2014 Aug;48(4):233-8. Epub 2014 Apr 22 PubMed: 24813062PAPER Wang HP, Wu HY
[Effect of Xiaoyao Powder on the ethology, morphology, and activities of neurotransmitters of Alzheimer's disease model mice].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Apr;34(4):471-4. PubMed: 24812907PAPER Holmes D
Steven Greenberg: putting CAA on the map.
Lancet Neurol. 2014 Apr;13(4):349. PubMed: 24646870PAPER Yau SY, Gil-Mohapel J, Christie BR, So KF
Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases?
Biomed Res Int. 2014;2014:403120. Epub 2014 Apr 9 PubMed: 24818140PAPER Olgiati S, De Rosa A, Quadri M, Criscuolo C, Breedveld GJ, Picillo M, Pappatà S, Quarantelli M, Barone P, De Michele G, Bonifati V
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family.
Neurogenetics. 2014 Aug;15(3):183-8. Epub 2014 May 10 PubMed: 24816432Current Filters
No filters selected